142 related articles for article (PubMed ID: 10974006)
1. Glucocorticoids antagonize AP-1 by inhibiting the Activation/phosphorylation of JNK without affecting its subcellular distribution.
González MV; Jiménez B; Berciano MT; González-Sancho JM; Caelles C; Lafarga M; Muñoz A
J Cell Biol; 2000 Sep; 150(5):1199-208. PubMed ID: 10974006
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids.
Bruna A; Nicolàs M; Muñoz A; Kyriakis JM; Caelles C
EMBO J; 2003 Nov; 22(22):6035-44. PubMed ID: 14609950
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
De Bosscher K; Vanden Berghe W; Haegeman G
Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
[TBL] [Abstract][Full Text] [Related]
4. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
[TBL] [Abstract][Full Text] [Related]
5. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway.
Caelles C; González-Sancho JM; Muñoz A
Genes Dev; 1997 Dec; 11(24):3351-64. PubMed ID: 9407028
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures.
Ventura JJ; Roncero C; Fabregat I; Benito M
Hepatology; 1999 Mar; 29(3):849-57. PubMed ID: 10051489
[TBL] [Abstract][Full Text] [Related]
7. Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: inhibition by glucocorticoids.
Olazabal I; Muñoz J; Ogueta S; Obregón E; García-Ruiz JP
Mol Endocrinol; 2000 Apr; 14(4):564-75. PubMed ID: 10770493
[TBL] [Abstract][Full Text] [Related]
8. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.
De Bosscher K; Beck IM; Dejager L; Bougarne N; Gaigneaux A; Chateauvieux S; Ratman D; Bracke M; Tavernier J; Vanden Berghe W; Libert C; Diederich M; Haegeman G
Cell Mol Life Sci; 2014 Jan; 71(1):143-63. PubMed ID: 23784308
[TBL] [Abstract][Full Text] [Related]
9. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
[TBL] [Abstract][Full Text] [Related]
11. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
[TBL] [Abstract][Full Text] [Related]
12. c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor.
Ventura JJ; Kennedy NJ; Lamb JA; Flavell RA; Davis RJ
Mol Cell Biol; 2003 Apr; 23(8):2871-82. PubMed ID: 12665585
[TBL] [Abstract][Full Text] [Related]
13. Antioxidants differentially regulate activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis.
Shrivastava A; Aggarwal BB
Antioxid Redox Signal; 1999; 1(2):181-91. PubMed ID: 11228746
[TBL] [Abstract][Full Text] [Related]
14. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by dexamethasone of interleukin 13 production via glucocorticoid receptor-mediated inhibition of c-Jun phosphorylation.
Hirasawa N; Izumi S; Linwong W; Ohuchi K
FEBS Lett; 2003 Nov; 554(3):489-93. PubMed ID: 14623117
[TBL] [Abstract][Full Text] [Related]
16. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
18. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation.
Itoh M; Adachi M; Yasui H; Takekawa M; Tanaka H; Imai K
Mol Endocrinol; 2002 Oct; 16(10):2382-92. PubMed ID: 12351702
[TBL] [Abstract][Full Text] [Related]
19. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun.
Liu H; Lo CR; Czaja MJ
Hepatology; 2002 Apr; 35(4):772-8. PubMed ID: 11915022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
